Purchases and Sales Made in Q3 2021 in Nurix Therapeutics, Inc. (NRIX)
This table provides information about the institutional ownership of Nurix Therapeutics, Inc. (NRIX) during Q3 2021. The information is specifically focused on institutions that hold shares of Nurix Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 15, 2021
Q3 2021
|
Euclidean Capital LLC
New York, NY |
SELL
|
- |
-154KClosed |
$3.51M - $5.67M
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-169K- 12.1% |
$3.83M - $6.19M
|
1.23M
$22.4M
|
|
|
Nov 15, 2021
Q3 2021
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-225KClosed |
$5.1M - $8.24M
|
0
$0
|
|
|
Nov 15, 2021
Q3 2021
|
State Street Corp
Boston, MA |
SELL
|
- |
-226K- 12.17% |
$5.14M - $8.3M
|
1.63M
$29.8M
|
|
|
Nov 15, 2021
Q3 2021
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-244KClosed |
$5.54M - $8.96M
|
0
$0
|
|
|
Nov 05, 2021
Q3 2021
|
Trv Gp Iii, LLC
Boston, MA |
SELL
|
- |
-1M- 29.22% |
$22.7M - $36.7M
|
2.42M
$44.2M
|
|
|
Nov 22, 2021
Q3 2021
|
Eco R1 Capital, LLC
San Francisco, CA |
SELL
|
- |
-1.25M- 52.59% |
$28.4M - $45.9M
|
1.13M
$20.5M
|